Chris Benko Presented on Using Wearable Technology in Clinical Trials

NEW YORK, Jan. 29, 2019 /PRNewswire/ — Koneksa Health, a private company that enables the biopharmaceutical industry to develop new medicines using innovative solutions such as digital biomarkers and novel clinical endpoints, announced today that CEO Chris Benko presented at the Keystone Symposia “Digital Health: From Science to Application” conference on Jan. 23.

This is the first digital health conference that focuses specifically on the scientific foundations and health applications of digital technologies. It is unique in providing a balanced input from stakeholders across sectors: academia, tech industry, venture capital, biopharma and regulators. The conference promotes discussion about the future of wearable technologies and digital medicine and what needs to happen to enable a wide integration of wearable technologies in healthcare and drug development.

Benko presented on the topic of “Using Wearable Technologies to Enable Novel Endpoint Development and Remote Data Collection in Clinical Trials,” in a session on “Applications of Digital Health Technologies to Drug Development.” The presentation highlighted advantages of using wearable devices in clinical development, described requirements for reliable data, and shared Koneksa’s experience in this work in more than 25 sponsored trials.

Other presenters in the drug development session included Andrea Coravos of Elektra Labs on “The Rise of Ethical Digital Medicine: Biomarkers, Diagnostics and Therapeutics,” Eric Perakslis of Harvard Medical School on “Digital Biomarkers and More Efficient Clinical Drug Development,” and Alessio Signorini of Evidation Health on “Digital Phenotyping and Post-Approval Monitoring of Drugs.”

Keystone Symposia on Molecular and Cellular Biology, a 501(c)(3) nonprofit organization, has been conducting internationally renowned open scientific conferences on topics ranging from cancer and immunology to neuroscience and genomics since 1972.

More information about the “Digital Health: From Science to Application” conference is available at

About Koneksa Health

Koneksa Health is a private company that enables the biopharmaceutical industry to develop new medicines with fewer patients. By unlocking the potential of real-world data from remote, wearable, and other digital technologies, Koneksa speeds up the time required to understand how a drug is working and helps to develop real-world evidence for how medicines can impact the daily lives of patients.

For more information, please visit